AAP newborn jaundice guideline comparison
Compare the practical differences between the older AAP 2004 hyperbilirubinemia workflow and the current AAP 2022 approach for newborn infants 35 or more weeks gestation.
Last reviewed: 2026-04-28
| Question | AAP 2004 | AAP 2022 | Documentation move |
|---|---|---|---|
| Guideline status | The 2004 AAP guideline was the long-standing reference for infants 35 or more weeks gestation. | The 2022 AAP clinical practice guideline revision is the current AAP framework for this population. | Use the 2022 workflow for current decisions unless a local protocol explicitly says otherwise. |
| Risk grouping | Risk categories combined gestational age and additional risk factors into low, medium, and higher risk groups. | Gestational age is handled directly, and neurotoxicity risk factors are selected separately. | Do not translate a 2004 risk group into a 2022 action without recalculating. |
| Phototherapy threshold | Phototherapy cutoffs were generally lower, which led to more treatment at bilirubin levels now often managed with close follow-up. | Phototherapy thresholds are generally higher and vary by age in hours, gestational age, and neurotoxicity risk state. | Use a 2022 calculator for the exact threshold and delta. |
| Exchange and escalation | Exchange transfusion thresholds were included, but the escalation workflow was less explicit for bedside handoff. | The 2022 approach emphasizes escalation of care when TSB is close to the exchange threshold. | Treat values near exchange as a NICU-level escalation pathway, not a routine recheck. |
| Follow-up after discharge | Bhutani-style risk-zone language was commonly used for follow-up thinking. | Follow-up is based on the bilirubin value's distance from the phototherapy threshold. | Document the delta from phototherapy and the repeat-bilirubin plan. |
| TcB confirmation | TcB was used for screening, but many workflows varied in when serum confirmation was required. | Confirm with TSB when TcB is near the phototherapy threshold or 15 mg/dL or higher. | Use TSB for final treatment decisions when TcB is close to action range. |
A 2004-era note may describe a risk zone or low/medium/high risk category. A 2022-era note should identify gestational age, neurotoxicity risk factors, the phototherapy threshold, the exchange threshold, and the value's delta from those thresholds.
Use the 2022 workflow for current AAP-based care. If your EHR, nursery, or regional policy still displays a 2004-style label, document that version and recalculate with current AAP 2022 thresholds before making a new treatment or discharge decision.
For a deeper input-by-input walkthrough, see how to use the bilirubin calculator.
Yes for current AAP guidance in newborn infants 35 or more weeks gestation. Local policies may lag during implementation, so document which guideline your setting uses.
Generally yes, but the exact threshold depends on age in hours, gestational age, and neurotoxicity risk factors. Use the current calculator rather than estimating from a comparison table.
Not cleanly. The 2022 approach separates gestational age from neurotoxicity risk factors, so old risk categories should be treated as historical context rather than direct calculator inputs.
For current AAP 2022 follow-up, use the difference between the bilirubin value and the phototherapy threshold. Bhutani-style risk-zone language is mainly useful for historical interpretation.
Keep the historical result labeled with its guideline version. For current care, recalculate using age in hours, gestational age, risk factors, and the 2022 threshold workflow.